About this event

  • Date and time Mon 16 Mar 2020 from 9:30am to 17 Mar 2020 at 5:10pm
  • Location Royal Society of Medicine
  • Organised by Radiology

This two-day event remains the only annual meeting in the UK that focuses on improving patient care in a clinical environment. Hear from world-renowned international experts about their clinical experiences and challenges as well as share your own experiences in a supportive friendly environment.

Day 1

Join us for an up to date overview of the current clinical applications and the emerging role of PET CT. A particular highlight of this year's meeting is a lecture on the new generation of fast PET CT scanners that is anticipated to revolutionise the use in patient care.

Day 2

Take a look into the future of PET CT, and embark on a journey from research to clinical usage. You will witness the steps taken to ultimately contribute to improving the care of people who require PET CT scanning. 

20% discount available for delegates attending both days of this meeting.

Attendees will:

  • Learn the current best practice with regards to clinical use of PET CT scanning
  • Recognise the pitfalls that can occur on PET CT scans in people with complex clinical problems and modern cancer treatments
  • Know some of the more unusual technical artefacts that can occur with PET CT scanning
  • Get a clear understanding of the role of PET CT in non-cancerous diseases
  • Identify the most recent advances in PET CT that can have an impact on clinical care
  • Appreciate the processes and challenges of introducing new PET CT tracers in the NHS

This meeting will be of interest to radiologists, nuclear medicine physicians, clinical oncologists, oncological surgeons, healthcare managers, commissioners of healthcare, PET CT physicists.

  • Join in the conversation online
  • Follow us on Twitter: @RoySocMed

Tickets

Early bird pricing available until 11 December 2019.

Member

RSM Fellow
Day 1 Day 2
£95.00 Day 1
£95.00 Day 2
RSM Associate
Day 1 Day 2
£55.00 Day 1
£55.00 Day 2
RSM Trainee
Day 1 Day 2
£55.00 Day 1
£55.00 Day 2
RSM Retired Fellow
Day 1 Day 2
£55.00 Day 1
£55.00 Day 2
RSM Student
Day 1 Day 2
£30.00 Day 1
£30.00 Day 2

Non - Member

Consultant / GP
Day 1 Day 2
£150.00 Day 1
£150.00 Day 2
AHP / Nurse / Midwife
Day 1 Day 2
£75.00 Day 1
£75.00 Day 2
Trainee
Day 1 Day 2
£75.00 Day 1
£75.00 Day 2
Student
Day 1 Day 2
£45.00 Day 1
£45.00 Day 2

Key speakers

Ramsey Badawi

Professor Ramsey Badawi

Chief of Nuclear Medicine and Vice-Chair for Research in the Department of Radiology, and Professor of Biomedical Engineering at UC Davis.

Speaker's biography

Professor Badawi has caused a sensation amongst the diagnostic imaging community with his invention of PET scanner, which simultaneously PET images all the organs and tissues in the body within 1 minute. 

Professor Rodney Hicks

Professor of Medicine and Radiology at the University of Melbourne and Director of the Centre for Cancer Imaging at the Peter MacCallum Cancer Centre in Melbourne, Australia.

Speaker's biography

Professor Hicks has pioneered the use of PET CT and has introduced a number of novel PET tracers in Australia. His group established the first pre-clinical PET imaging facility in Australia in 2002.

Dr Benoy Daniel

Senior Medical Assessor, Medicines and Health Products Regulatory Agency (MHRA)

Agenda

Day 1

Registration, tea and coffee

Session one: PET-CT and New Technologies: to be fore-warned is to be fore-armed

Chair: Dr Bal Sanghera, Inaugural Chief Scientific Officer’s Knowledge Transfer Partnership Associate

Artefacts in PET-CT: A physicist’s perspective

Professor Bernhard Sattler, Head Medical Physics Nuclear Medicine Associate Professor of Medical Engineering, University Hospital Leipzig

Artefacts in PET-CT: A radiologist’s perspective  

Dr Rohit Kochlar, Consultant Radiologist the Christie NHS Foundation Trust Senior Lecturer, University of Manchester

New algorithms: Added value and pitfalls

Dr Bal Sanghera, Inaugural Chief Scientific Officer’s Knowledge Transfer Partnership Associate

Panel discussion
Tea and coffee break

Session two: Prostate cancer PET-CT

Chair: TBC

Beyond bone scanning: The emerging role of molecular imaging in prostate cancer

Professor Rodney Hicks, Professor of Medicine and Radiology, University of Melbourne Director of the Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne

Flucyclovine imaging

Professor Andy Scarsbrook, Leeds Associate Professor of Radiology Leeds Royal Infirmary Leeds

Flucyclovine: how I report them and pitfalls

Dr Paolo Castelluci, Consultant Physician, S.Orsola Malpighi Hospital,  Bologna

Panel discussion
Lunch

Session three: Advances on therapy and new roles for Positron Emission Tomography - Computed Tomography (PET-CT)

Chair: Professor Gary Cook, London 

Response evaluation criteria in solid tumors (RECIST) v1.1 pearls and pitfalls
PET-CT appearance of Immunotherapy treatment

Professor Gary Cook, Professor of PET-CT, Kings College London  

PET-CT and breast cancer

Professor Lioe-Fee de Geus-Oei, Nuclear Medicine Physician, Leiden University Medical Center, Leiden

PET for therapeutic response assessment: Beyond harmony, we need to be singing the same song

Professor Rodney Hicks, Professor Rodney Hicks, Professor of Medicine and Radiology, University of Melbourne Director of the Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne

Panel discussion
Tea and coffee break

Session four: The Informed Reporter

PET-CT and vasculitis

Professor Roland Hustinx, Service de Médecine nucléaire et d'Imagerie oncologique, Département de Physique médicale, Centre Hospitalier Universitaire de Liège, Université de Liège 

PET-CT applications in people with rhematological disorders
PET-CT imaging of infection- the 2020 update

Professor Ora Israel, Professor of Imaging, Rappaport Faculty of Medicine,  Technion, Israel Institute of Technology

Infection: Difficult cases and how I reported them

Professor Iain Lyburn, Consultant Radiologist, Gloucestershire Hospitals, NHS Foundation Trust, Cheltenham

Panel discussion
Close of meeting
Day 2

Registration, tea and coffee

Session one: Gallium-68 PET-CT

Chair: Professor Val Lewington, London 

Gallium-peptide PET-CT: Impact on decision making in people with neuro-endocrine tumours

Dr Amy Eccles, Consultant Nuclear Medicine Radiologist, Guys and St Thomas’ hospital, London

Gallium-68 PSMA PET-CT: Its pros and its cons

Dr Dr Tara Barwick Consultant Nuclear Medicine Physician Imperial College Hospital

Normal and abnormal F DOPA whole body PET-CT

Professor Ora Israel, Professor of Imaging,  Rappaport Faculty of Medicine,  Technion, Israel Institute of Technology

Panel discussion
Tea and coffee break

Session two: Horizon scanning

Chair: Dr Wai Lup Wong, Consultant Radiologist in Nuclear Medicine East and North Herts NHS Trust Clinical Guardian PET CT NHS England National Speciality Advisor PET CT NHS England

Explorer: First clinical implementation of Total-body PET

Professor Ramsey Badawi, Vice-Chair for Research, Department of Radiology University of California Davis, Chief of Nuclear Medicine, University of California Davis

Total-body PET: what might the future hold?

Professor Ramsey Badawi, Vice-Chair for Research, Department of Radiology University of California Davis, Chief of Nuclear Medicine, University of California Davis

Panel discussion
International collaboration and driving this forward to optimise service

Chair: Professor Rod Hicks, Melbourne

Charlotte Lynch, Research  Officer International Cancer Benchmarking Partnership, Cancer Research UK

Deanne Langer, Manager, Cancer Imaging Program Clinical Programs and Quality Initiatives Cancer Care Ontario

Panel discussion
Lunch

Session three: PET-CT: Implementation of change at scale and pace

Chair: Dr Mark Lambert, Consultant in Specialised Services Public Health at Public Health England, Newcastle upon Tyne 

Medicines and Healthcare products Regulatory Agency (MHRA): the licencing process

Dr Benoy Daniel, Senior Medical Assessor Medicines and Health Products Regulatory Agency 

Implementing PET-CT service developments into the NHS in England

Nicky McCullough, Head of the Cancer Programme of Care Specialised Commissioning NHS England

The journey from research to clinical usage within the NHS: an industry perspective

Ted Broadbent, Head of Commercial Operations Blue Earth Diagnostics

Implementation of change

Contribution from Department of Management, Birkbeck University of London 

Panel discussion
Tea and coffee break

Session four: Frequently asked questions [FAOs]

Chair: Dr Richard Graham, Consultant Radiologist United Hospitals Bath President Radiology Section Royal Society of Medicine   

Do we really need PET-CT in the imaging of gliomas?

Professor Susan Short, Professor of Clinical Oncology and Neuro-oncology University of Leeds

Incidental PET-CT findings in people with lung cancer: which do you need to report?

Dr Jeanette Dickson, Consultant Clinical Oncologist, President Royal College of Radiologists UK

PET CT reports: are we being understood?

Dr Thomas Wagner, Consultant Physician, Royal Free Hospital, London

Learning, interesting, challenging cases with PET-CT

Professor Sabina Dizdarevic, Principal Lead Consultant in Imaging and Nuclear Medicine, Imaging and Nuclear Medicine Department, Brighton, Sussex University Hospitals NHS Trust Honorary Clinical Professor University of Sussex and Brighton

PET-CT with intravenous contrast: How we do it

Professor Iain Lyburn, Consultant Radiologist, Gloucestershire Hospitals NHS Foundation Trust

Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom